Leaflet FERRETAB 50mg / 0.5mg prolonged release capsules
Indicated for: vitamin deficiency
Route of administration: oral
Substance: ferrous fumarate + folic acid (vitamins)
ATC: B03AD02 (Blood and blood forming organs | Iron preparations | Iron in combination with folic acid)
Take this medicine on an empty stomach.
Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.
Ferrous fumarate and folic acid are two substances used together to prevent and treat anemia caused by iron and folic acid deficiency, especially in pregnant women or people with increased needs for these nutrients. Iron helps form hemoglobin, while folic acid is essential for the production of healthy red blood cells and the normal development of the fetus.
This supplement is usually taken as tablets, according to your doctor's instructions. The dose and duration of treatment vary depending on individual needs and blood test results. It is important not to exceed the recommended dose and to follow your doctor's advice to avoid side effects.
Side effects may include nausea, stomach discomfort, constipation, or, more rarely, allergic reactions. To reduce the risk of stomach irritation, it is recommended to take the supplement after meals. If you experience unusual or severe reactions, contact your doctor.
Ferrous fumarate and folic acid are essential for blood health and for preventing complications during pregnancy. Follow medical advice and do not stop treatment without your specialist's approval to ensure the therapy's effectiveness and safety.
General data about FERRETAB 50mg / 0.5mg
- Substance: ferrous fumarate + folic acid
- Date of latest medicines list: 01-08-2024
- Product code: W01714005
- Concentration: 50mg / 0.5mg
- Pharmaceutical form: prolonged release capsules
- Quantity: 100
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.